eMedicine Specialties > Radiology > Genitourinary

Hyperaldosteronism: Imaging

Author: Ali Nawaz Khan, MBBS, FRCS, FRCP, FRCR, Consultant Radiologist, North Manchester General Hospital, The Pennine Acute NHS Trust, Manchester UK
Coauthor(s): Sumaira MacDonald, MBChB, PhD, MRCP, FRCR, Lecturer, Sheffield University Medical School; Endovascular Fellow, Sheffield Vascular Institute; Durre Sabih, MBBS, MSc, Visiting Faculty, Department of Nuclear Medicine, Pakistan Institute Applied Sciences and Nishtar Medical College; Director, Multan Institute of Nuclear Medicine and Radiotherapy; Muhammad Sohaib, MBBS, MSc, Senior Medical Officer, Assistant Professor, Department of Medical Sciences, Pakistan Institute of Engineering and Applied Sciences
Contributor Information and Disclosures

Updated: Apr 8, 2008

Radiography

Findings

Conventional radiography has no role in the diagnosis of APA.

Computed Tomography

Findings


Axial enhanced CT scan in a 32-year-old woman who...

Axial enhanced CT scan in a 32-year-old woman who presented with hypertension shows a low-attenuating 2.8-cm suprarenal mass (A) (same patient as in Image 1 in Multimedia). Histologic results obtained after surgery confirmed a tumor due to Conn syndrome.

Axial enhanced CT scan in a 32-year-old woman who...

Axial enhanced CT scan in a 32-year-old woman who presented with hypertension shows a low-attenuating 2.8-cm suprarenal mass (A) (same patient as in Image 1 in Multimedia). Histologic results obtained after surgery confirmed a tumor due to Conn syndrome.


Axial nonenhanced CT scan through the adrenal gla...

Axial nonenhanced CT scan through the adrenal glands in 56-year-old man shows multiple nodules in both glands, although biochemical results indicated primary aldosteronism. The patient received medical treatment.

Axial nonenhanced CT scan through the adrenal gla...

Axial nonenhanced CT scan through the adrenal glands in 56-year-old man shows multiple nodules in both glands, although biochemical results indicated primary aldosteronism. The patient received medical treatment.


Axial enhanced CT scan in a 56-year-old man shows...

Axial enhanced CT scan in a 56-year-old man shows no enhancement of the adrenal masses (same patient as in Image 3 in Multimedia).

Axial enhanced CT scan in a 56-year-old man shows...

Axial enhanced CT scan in a 56-year-old man shows no enhancement of the adrenal masses (same patient as in Image 3 in Multimedia).


Axial nonenhanced CT scan through the adrenal gla...

Axial nonenhanced CT scan through the adrenal glands in a 60-year-old patient who presented with hypertension and hypokalemia shows a bilobulated tumor in the right adrenal gland.

Axial nonenhanced CT scan through the adrenal gla...

Axial nonenhanced CT scan through the adrenal glands in a 60-year-old patient who presented with hypertension and hypokalemia shows a bilobulated tumor in the right adrenal gland.


Axial enhanced CT scan through the adrenal glands...

Axial enhanced CT scan through the adrenal glands in a 60-year-old patient who presented with hypertension and hypokalemia shows minor tumor enhancement (same patient as in Image 5 in Multimedia). Note the normal left adrenal gland.

Axial enhanced CT scan through the adrenal glands...

Axial enhanced CT scan through the adrenal glands in a 60-year-old patient who presented with hypertension and hypokalemia shows minor tumor enhancement (same patient as in Image 5 in Multimedia). Note the normal left adrenal gland.


A 59-year-old man was referred for renal ultrason...

A 59-year-old man was referred for renal ultrasonography as a part of the workup for newly diagnosed hypertension. The sonogram depicted a 3-cm right adrenal mass, which was regarded as an incidentaloma (not shown). Axial enhanced CT scan through the adrenal gland shows minor patchy enhancement in a right adrenal tumor.

A 59-year-old man was referred for renal ultrason...

A 59-year-old man was referred for renal ultrasonography as a part of the workup for newly diagnosed hypertension. The sonogram depicted a 3-cm right adrenal mass, which was regarded as an incidentaloma (not shown). Axial enhanced CT scan through the adrenal gland shows minor patchy enhancement in a right adrenal tumor.


After a diagnosis of hyperaldosteronism has been established clinically and biochemically, dedicated CT scanning of the adrenal glands is performed using thin (3-mm) collimation. Nonenhanced and enhanced CT scans are obtained.6,7,9,12,13

The mean attenuation level in adrenal adenomas is -2.2 HU. Among hyperfunctioning adenomas, aldosteronomas have the lowest attenuation levels. In patients with primary hyperaldosteronism, CT scan findings may be normal, or scans may show nodular or multinodular glands.

Degree of Confidence

CT scanning has a sensitivity of 60-80% in detecting APAs. CT appears more reliable at revealing tumors larger than 1 cm. Conversely, 20% of tumors may be missed. In one series, the average diameter of an APA was 18 mm, and 20% tumors were smaller than 1 cm. With earlier-generation CT scanners, the sensitivity for detecting APAs was 50-70%. The sensitivity of current scanners has been improved to 82-88%. The specificity of CT scanning in the detection of APAs is 77%.6,7,12,13

False Positives/Negatives

CT scan findings of ipsilateral or contralateral, nonfunctioning adenomas lead to a false-positive diagnosis of adrenal hyperplasia. CT scanning is not reliable in distinguishing hyperplasia from adenoma in patients with multiple, bilateral nodules.

Magnetic Resonance Imaging

Findings

Early experience with MRI in the diagnosis of APA has been encouraging. APAs are iso-intense or hypo-intense relative to the liver on T1-weighted images; they are slightly hyperintense on T2-weighted images. Chemical-shift imaging is a useful method for the characterization of adrenal masses. It is based on the principle that fat protons precess faster than do water protons. Chemical-shift MRI is highly sensitive and specific for the differentiation of benign from malignant adrenal tumors, because benign adrenal tumors contain fat, while malignant adrenal tumors rarely do. With chemical-shift imaging, the signal intensity has been found to decrease on out-of-phase images in 86% of patients with APAs and in 89% of patients with bilateral adrenal hyperplasia.8,9,10,11

Degree of Confidence

A sensitivity of 70-100% and a specificity of 64-100% have been reported in the detection of APAs with MRI.8,9,10,11

False Positives/Negatives

False-positive diagnoses have occurred in cases of idiopathic hyperaldosteronism, bilateral nodular hyperplasia, primary hypertension, and primary hypertension associated with nonfunctioning adrenal adenoma.

Ultrasonography

Findings


Longitudinal sonogram through the left kidney in ...

Longitudinal sonogram through the left kidney in a 32-year-old woman who presented with hypertension shows a 3-cm hypoechoic but solid mass superior to the upper pole of the kidney. Initially, the mass was regarded as a nonfunctioning adenoma unrelated to the patient's hypertension. Subsequently, mild hypokalemia developed. Surgical resection confirmed a tumor due to Conn syndrome.

Longitudinal sonogram through the left kidney in ...

Longitudinal sonogram through the left kidney in a 32-year-old woman who presented with hypertension shows a 3-cm hypoechoic but solid mass superior to the upper pole of the kidney. Initially, the mass was regarded as a nonfunctioning adenoma unrelated to the patient's hypertension. Subsequently, mild hypokalemia developed. Surgical resection confirmed a tumor due to Conn syndrome.


Ultrasonograms may reveal a significantly sized APA, but because APAs tend to be small, the overall sensitivity of ultrasonography is poor. Compared with the adrenal tumors in Cushing disease, larger APAs are easier to identify, because neither retroperitoneal nor subcutaneous fat is obtrusive, as it is with Cushing disease.

Degree of Confidence

Ultrasonographic findings contribute little to the diagnosis unless the adrenal tumor is large, which is seldom the case. However, ultrasonography is an excellent modality for the investigation of hypertension.

False Positives/Negatives

The exact sensitivity of ultrasonography in the diagnosis of APA is not known, but it appears to be low. Similar to other types of cross-sectional imaging, ultrasonography may incidentally demonstrate nonfunctioning masses in the adrenal glands.

Nuclear Imaging

Findings


Scintigram obtained by using iodine-131-6<FONT st...

Scintigram obtained by using iodine-131-6β-iodomethylnorcholesterol (NP-59) in a 59-year-old man with hypertension shows fairly intense radionuclide uptake in the right adrenal tumor (same patient as in Image 7 in Multimedia). At surgery, a Conn tumor was confirmed.

Scintigram obtained by using iodine-131-6<FONT st...

Scintigram obtained by using iodine-131-6β-iodomethylnorcholesterol (NP-59) in a 59-year-old man with hypertension shows fairly intense radionuclide uptake in the right adrenal tumor (same patient as in Image 7 in Multimedia). At surgery, a Conn tumor was confirmed.


Iodine-131-6 β -iodomethylnorcholesterol (NP-59) is a cholesterol analog that binds to low-density lipoprotein receptors of the adrenal cortex and is the primary radionuclide used to image the adrenal cortex.12 Imaging is usually performed after dexamethasone suppression to reduce high background tracer uptake by the zona fasciculata. The normal glands (which show uptake of the radionuclide) are identified on day 5 or thereafter. Early, bilateral depiction of the glands (that is, before day 5) implies adrenal hyperplasia, whereas early, unilateral early depiction implies an APA. Detection rate of APA can be improved by using single-photon emission CT (SPECT) scanning.13

Degree of Confidence

CT scanning is an excellent modality for the detection of APAs; bilateral hyperplasia is usually inferred by the absence of an adrenal tumor. In contrast, NP-59 scanning provides a specific diagnosis of adrenal hyperplasia. Accuracy and sensitivity of 80-95% can be obtained. Smaller adenomas, which are not clearly depicted on CT scans, can be detected on NP-59 scans.13

False Positives/Negatives

Primary aldosteronism must be clinically and biochemically diagnosed before the radionuclide study is performed, because secondary hyperaldosteronism produces bilateral tracer uptake that is indistinguishable from that of primary, autonomous, bilateral hyperplasia. In addition, all drugs that disturb the renin-angiotensin-aldosterone axis must be withdrawn before imaging. The extremely rare mineralocorticoid-secreting carcinoma also demonstrates NP-59 uptake.13

Scintigraphy must be performed in the appropriate clinical setting, because NP-59 uptake has been described in benign, nonsecretory adenoma, as well as in metastatic lung cancer, metastatic colon cancer, lymphoma, myelolipoma, ganglioneuroma, adrenal cysts, and adrenocortical carcinoma. Tracer uptake at extra-adrenal sites also has been reported.13

Angiography

Findings

Because APAs are small and are not usually vascular, selective adrenal angiography is seldom helpful. However, adrenal phlebography has a useful role in the investigation of APA, because the splaying of veins around APAs can help in identifying even small tumors. If contrast medium is refluxed into the veins of the APA, a wheel-spoke pattern is seen in the intratumoral veins. Because APAs are small, a vigorous retrograde venous injection is usually required to detect the tumors; this vigorous injection is not without risk, because extravasation may occur.

Extravasation is a particular problem if the catheter is wedged into the vein. Extravasation can be painful and has been associated with adrenal infarction. Adrenal vein thrombosis is also a known complication of adrenal phlebography, which has been linked to adrenal infarction. Adrenal insufficiency has been described as a result of bilateral adrenal infarction. Adrenal vein thrombosis is more likely to occur if the catheter is wedged in the adrenal vein and left there for several minutes during the procedure.

The most useful technique in the investigation of primary aldosteronism is adrenal venous sampling.7,9,14 Blood samples are obtained from both adrenal veins for aldosterone level analysis; hormone level ratios are compared with each other and with levels in the inferior vena cava below the adrenal veins. In experienced hands, this technique can achieve a high sensitivity; however, it is a time-consuming procedure that necessitates prolonged cannulation of adrenal veins and increases the risk of adrenal vein thrombosis. In addition, the adrenal veins are small, and collecting 7 mL of blood for sampling is not easy. This is particularly a problem when blood is collected from the right adrenal vein, in which a short vein enters the inferior vena cava directly.

Some venous samples thus acquired may be diluted by blood from the inferior vena cava on the right and from the phrenic or renal vein on the left. To overcome the problem of dilution, cortisol levels can be measured from the same samples. A low cortisol level suggests dilution by nonadrenal blood, whereas a high cortisol level indicates a relatively pure sample. When aldosterone and cortisol are measured in blood samples from the same site, an aldosterone-cortisol ratio that corrects the concentration of aldosterone for dilution can be calculated.

Degree of Confidence

An accuracy of 95% and a sensitivity of 75% have been reported with adrenal venous sampling. Adrenal venous sampling is required for the definitive diagnosis of primary aldosteronism and for the detection of laterality of the adrenal lesion.14

Zarnegar and colleagues conducted a study of 59 patients with biochemically diagnosed hyperaldosteronism who subsequently underwent unilateral adrenalectomy.15 Clinical decision in proceeding to surgery was based on CT scanning alone (n=30) or on CT scanning and adrenal venous sampling (n=29). The authors found that in the 2 groups, adrenalectomy had similar clinical effects. CT scanning can be used to reliably diagnose adenomas larger than 1.0 cm. The authors recommended that adrenal venous sampling be reserved for cases in which CT scan findings are equivocal or in which both of the patient's adrenal glands are abnormal.

False Positives/Negatives

The dilution of blood from the inferior vena cava on the right and from the renal or phrenic vein on the left can lead to erroneous results in adrenal venous sampling.

More on Hyperaldosteronism

Overview: Hyperaldosteronism
Imaging: Hyperaldosteronism
Follow-up: Hyperaldosteronism
Multimedia: Hyperaldosteronism
References

References

  1. Gallay BJ, Ahmad S, Xu L, et al. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. Am J Kidney Dis. Apr 2001;37(4):699-705. [Medline].

  2. Pratt JH. Low-renin hypertension: more common than we think?. Cardiol Rev. Jul-Aug 2000;8(4):202-6. [Medline].

  3. Leung AM, Sasano H, Nishikwa T, et al. Multiple unilateral adrenal adenomas in a patient with primary hyperaldosteronism. Endocr Pract. Jan-Feb 2008;14(1):76-9. [Medline].

  4. Pimenta E, Calhoun DA. Resistant hypertension and aldosteronism. Curr Hypertens Rep. Nov 2007;9(5):353-9. [Medline].

  5. Jung SI, Kim SO, Kang TW, et al. Bilateral adrenal myelolipoma associated with hyperaldosteronism: report of a case and review of the literature. Urology. Dec 2007;70(6):1223.e11-3. [Medline].

  6. Mayo-Smith WW, Boland GW, Noto RB, et al. State-of-the-art adrenal imaging. Radiographics. Jul-Aug 2001;21(4):995-1012. [Medline][Full Text].

  7. Magill SB, Raff H, Shaker JL, et al. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab. Mar 2001;86(3):1066-71. [Medline][Full Text].

  8. Wang JH, Wu HM, Sheu MH, et al. High resolution MRI of adrenal glands in patients with primary aldosteronism. Chung Hua I Hsueh Tsa Chih (Taipei). Jun 2000;63(6):475-81. [Medline].

  9. Rossi GP, Sacchetto A, Chiesura-Corona M, et al. Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab. Mar 2001;86(3):1083-90. [Medline][Full Text].

  10. Rossi GP, Chiesura-Corona M, Tregnaghi A, et al. Imaging of aldosterone-secreting adenomas: a prospective comparison of computed tomography and magnetic resonance imaging in 27 patients with suspected primary aldosteronism. J Hum Hypertens. Aug 1993;7(4):357-63. [Medline].

  11. Sohaib SA, Peppercorn PD, Allan C, et al. Primary hyperaldosteronism (Conn syndrome): MR imaging findings. Radiology. Feb 2000;214(2):527-31. [Medline][Full Text].

  12. Nocaudie-Calzada M, Huglo D, Lambert M, et al. Efficacy of iodine-131 6beta-methyl-iodo-19-norcholesterol scintigraphy and computed tomography in patients with primary aldosteronism. Eur J Nucl Med. Oct 1999;26(10):1326-32. [Medline].

  13. Hwang I, Balingit AG, Georgitis WJ, et al. Adrenocortical SPECT using iodine-131 NP-59. J Nucl Med. Aug 1998;39(8):1460-3. [Medline][Full Text].

  14. Nishikawa T, Saito J, Omura M. Adrenal venous sampling is absolutely requisite for definitively diagnosing primary aldosteronism as well as for detecting laterality of the adrenal lesion. Hypertens Res. Nov 2007;30(11):1009-10. [Medline][Full Text].

  15. Zarnegar R, Bloom AI, Lee J, et al. Is adrenal venous sampling necessary in all patients with hyperaldosteronism before adrenalectomy?. J Vasc Interv Radiol. Jan 2008;19(1):66-71. [Medline].

  16. Moo TA, Zarnegar R, Duh QY. Prediction of successful outcome in patients with primary aldosteronism. Curr Treat Options Oncol. Aug 2007;8(4):314-21. [Medline].

  17. Haenel LC 4th, Hermayer KL. A case of unilateral adrenal hyperplasia: the diagnostic dilemma of hyperaldosteronism. Endocr Pract. Mar-Apr 2000;6(2):153-8. [Medline].

  18. Stowasser M. Primary aldosteronism: rare bird or common cause of secondary hypertension?. Curr Hypertens Rep. Jun 2001;3(3):230-9. [Medline].

Further Reading

Keywords

primary hyperaldosteronism, primary aldosteronism, Conn syndrome, aldosterone hypersecretion, adrenal adenoma, adrenal gland tumor, adrenal gland hyperplasia, aldosterone-producing tumor, adrenal gland carcinoma, aldosterone excess, aldosterone-producing adenoma, APA, aldosterone-producing adrenal adenoma, aldosteronoma, secondary aldosteronism, idiopathic hyperaldosteronism

Contributor Information and Disclosures

Author

Ali Nawaz Khan, MBBS, FRCS, FRCP, FRCR, Consultant Radiologist, North Manchester General Hospital, The Pennine Acute NHS Trust, Manchester UK
Ali Nawaz Khan, MBBS, FRCS, FRCP, FRCR is a member of the following medical societies: American Institute of Ultrasound in Medicine, Royal College of Physicians, Royal College of Physicians and Surgeons of the United States, Royal College of Radiologists, and Royal College of Surgeons of England
Disclosure: Nothing to disclose.

Coauthor(s)

Sumaira MacDonald, MBChB, PhD, MRCP, FRCR, Lecturer, Sheffield University Medical School; Endovascular Fellow, Sheffield Vascular Institute
Sumaira MacDonald, MBChB, PhD, MRCP, FRCR is a member of the following medical societies: British Medical Association, Royal College of Physicians, and Royal College of Radiologists
Disclosure: Nothing to disclose.

Durre Sabih, MBBS, MSc, Visiting Faculty, Department of Nuclear Medicine, Pakistan Institute Applied Sciences and Nishtar Medical College; Director, Multan Institute of Nuclear Medicine and Radiotherapy
Disclosure: Nothing to disclose.

Muhammad Sohaib, MBBS, MSc, Senior Medical Officer, Assistant Professor, Department of Medical Sciences, Pakistan Institute of Engineering and Applied Sciences
Disclosure: Nothing to disclose.

Medical Editor

John L Haddad, MD, Clinical Associate Professor, Department of Radiology, Weill Medical College of Cornell University; Director of Body MRI, Department of Radiology, Methodist Hospital in Houston
John L Haddad, MD is a member of the following medical societies: American College of Radiology, American Medical Association, and Radiological Society of North America
Disclosure: Nothing to disclose.

Pharmacy Editor

Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.

Managing Editor

Joshua A Becker, MD, Professor, Department of Radiology, New York University School of Medicine
Joshua A Becker, MD is a member of the following medical societies: Society of Uroradiology
Disclosure: Nothing to disclose.

CME Editor

Robert M Krasny, MD, Consulting Staff, Department of Radiology, Resolution Imaging Medical Corporation
Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America
Disclosure: Nothing to disclose.

Chief Editor

Eugene C Lin, MD, Consulting Radiologist, Virginia Mason Medical Center; Clinical Assistant Professor of Radiology, University of Washington School of Medicine
Eugene C Lin, MD is a member of the following medical societies: American College of Nuclear Medicine, American College of Radiology, Radiological Society of North America, and Society of Nuclear Medicine
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.